Mar 8, 2022
#ACTRIMS2022 – Cognitive Training Paired With tDCS Aids Patients Electrically stimulating the brain while doing at-home cognitive training games can help to prevent a decline in cognition for people with multiple sclerosis (MS), particularly those with more advanced...
Mar 8, 2022
Bafiertam is a new oral Disease-Modifying Therapy for relapsing forms of MS. The active ingredient in Bafiertam is Monomethyl Fumarate or MMF. It has the same active ingredient as other fumarates (Tecfidera and Vumerity). Bafiertam has the same established efficacy...
Feb 28, 2022
Multiple sclerosis (MS) treatments belonging to the class of sphingosine 1-phosphate (S1P) receptor modulators — such as Mayzent (siponimod) and Gilenya (fingolimod) — may be associated with a greater likelihood of skin cancer, results from a real-world study suggest....
Feb 28, 2022
The past two weeks have been a bit of a blur. Our younger son caught the COVID-19 virus at school, and once we got a positive home test, we went into containment mode. While I took him to get an official test at a local clinic, my husband got everything set up for the...
Feb 28, 2022
People with multiple sclerosis (MS) may experience symptoms for years before being diagnosed with the condition, a German study indicates. Some scientists previously believed early symptoms indicated a person may be developing MS, not that the person already had the...
Feb 27, 2022
The majority of people living with multiple sclerosis (MS) are initially diagnosed with relapsing-remitting MS, meaning they experience periods of acute symptoms, called relapses or exacerbations, that are generally followed by periods with minimal, or at least less...
